INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 26 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $13,509,377 | +4.9% | 13,507,000 | +3.8% | 0.41% | -6.4% |
Q4 2022 | $12,877,281 | +318.6% | 13,007,000 | +311.2% | 0.44% | +601.6% |
Q3 2022 | $3,076,000 | +0.3% | 3,163,000 | 0.0% | 0.06% | +51.2% |
Q2 2022 | $3,068,000 | +0.6% | 3,163,000 | -4.7% | 0.04% | +46.4% |
Q1 2022 | $3,050,000 | -3.0% | 3,320,000 | 0.0% | 0.03% | +64.7% |
Q4 2021 | $3,144,000 | -94.6% | 3,320,000 | -94.9% | 0.02% | -92.8% |
Q2 2021 | $58,191,000 | +40.3% | 64,548,000 | +28.8% | 0.24% | +12.9% |
Q1 2021 | $41,465,000 | +199.4% | 50,109,000 | +186.3% | 0.21% | +198.6% |
Q4 2020 | $13,850,000 | – | 17,500,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 5,324,000 | $4,995,000 | 3.78% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $53,020,000 | 2.12% |
DLD Asset Management, LP | 32,500,000 | $30,048,000 | 2.06% |
Castle Creek Arbitrage, LLC | 4,504,000 | $4,161,000 | 1.43% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 10,000,000 | $9,372,000 | 0.62% |
Graham Capital Management, L.P. | 14,636,000 | $13,509,000 | 0.60% |
OAKTREE CAPITAL MANAGEMENT LP | 64,452,000 | $59,704,000 | 0.54% |
Context Capital Management, LLC | 1,000,000 | $926,000 | 0.52% |
ADVENT CAPITAL MANAGEMENT /DE/ | 23,118,000 | $21,341,000 | 0.52% |
WOLVERINE ASSET MANAGEMENT LLC | 18,583,000 | $17,322,000 | 0.21% |